SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: YABABY! who wrote (944)8/14/1998 1:17:00 AM
From: Wisee  Read Replies (2) of 1185
 
YABABY,

I don't think we will see any action on Nortran until late 1998 or early 1999. By then we could see a) Hoffman LaRoche exercising their option on the heart drug b) a licensing deal for the labido drug c) a licensing deal for the cough drug. I think if any one of these three comes through, Nortran could justify a market cap. of US$100 million or $4 Canadian. This is similar to the target price that Global Securities recently put on Nortran. A 400% return in six months is not bad, and no heavy lifting is required!!

Short term pain, long term gain,
Wisee
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News